Frampton’s (35) finding showed that crExos GPC-1 could not discriminate between PDAC and benign pancreatic disease (IPMN, CP, and serous cystadenoma). The gene discussed is GPC1; the disease is pancreatic intraductal papillary-mucinous neoplasm.